VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,515 | -12.5% | 93,452 | -2.1% | 0.00% | 0.0% |
| Q2 2023 | $2,875 | +12.4% | 95,481 | +20.7% | 0.00% | +33.3% |
| Q1 2023 | $2,558 | +12.8% | 79,084 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,267 | -99.9% | 79,084 | -20.2% | 0.00% | 0.0% |
| Q3 2022 | $2,390,000 | +132.7% | 99,084 | +164.2% | 0.00% | +200.0% |
| Q2 2022 | $1,027,000 | +24.3% | 37,497 | +74.0% | 0.00% | 0.0% |
| Q1 2022 | $826,000 | -59.3% | 21,551 | -66.0% | 0.00% | -50.0% |
| Q4 2021 | $2,030,000 | +1281.0% | 63,371 | +1167.4% | 0.00% | – |
| Q3 2021 | $147,000 | -13.5% | 5,000 | 0.0% | 0.00% | – |
| Q2 2021 | $170,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |